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DOI 10.1016/j.chom.2011.12.005SUMMARY et al., 1995; Rowell et al., 1995) and to associate with the matrixThe human and simian immunodeficiency viruses
(HIV and SIV) primarily infect lymphocytes, which
must be activated for efficient viral replication. We
show that the cytoplasmic domain of the transmem-
brane glycoprotein gp41 (gp41CD) of both HIV-1 and
SIV induces activation of NF-kB, a cellular factor
important for proviral genome transcription and
lymphocyte activation. This NF-kB activating prop-
erty localized to a region 12–25 (SIV) or 59–70 (HIV-1)
residues from the gp41 membrane-spanning
domain. An siRNA-based screen of 42 key NF-kB
regulators revealed that gp41CD-mediated activa-
tion occurs through the canonical NF-kB pathway
via TGF-b-activated kinase 1 (TAK1). TAK1 activity
was required for gp41CD-mediated NF-kB activa-
tion, and HIV-1-derived gp41CD physically inter-
acted with TAK1 through the same region required
for NF-kB activation. Importantly, an NF-kB activa-
tion-deficient HIV-1 mutant exhibited increased
dependence on cellular activation for replication.
These findings demonstrate an evolutionarily
conserved role for gp41CD in activating NF-kB to
promote infection.
INTRODUCTION
Members of the genus Lentivirus, familyRetroviridae, have trans-
membrane envelope glycoproteins (TM) with unusually long
cytoplasmic domains. The cytoplasmic domain of lentiviral TM
is typically 150–200 amino acids in length, compared to only
30–40 amino acids found in the members of other Retroviridae
genera (Evans et al., 2002). For the human and simian immuno-
deficiency viruses, most of these cytoplasmic domain
sequences are dispensable for viral replication in certain cell
types (Akari et al., 2000; Hirsch et al., 1989;Murakami and Freed,
2000b; Wilk et al., 1992; Yuste et al., 2004). Sequences in the
cytoplasmic domain (CD) of the TM protein of HIV and SIV,
commonly designated as gp41, have been shown to regulate
the rate of endocytosis of the viral envelope complex from the
surface of the cell (Berlioz-Torrent et al., 1999; LaBrancheCell Host &protein in the process of virion assembly (Freed and Martin,
1996; Gonza´lez et al., 1996; Lopez-Verge`s et al., 2006; Manrique
et al., 2008; Murakami and Freed, 2000a). Additionally, several
cellular interaction partners of gp41CD have been reported,
including calmodulin (Srinivas et al., 1993), a-catenin (Kim
et al., 1999), the guanine nucleotide exchange factor p115-
RhoGEF (Zhang et al., 1999), the prenylated Rab acceptor
PRA1 (Evans et al., 2002), the transcription factor luman (Blot
et al., 2006), and, most recently, prohibitin 1 and 2 (Emerson
et al., 2010). The physiological relevance of some of these inter-
actions remains poorly understood; other functional contribu-
tions of the long gp41CD have not been described.
Nuclear factor-kappaB (NF-kB) consists of a family of tran-
scription factors which act as central regulators in various
cellular processes, including innate and adaptive immunity, cell
survival, proliferation, and differentiation (Oeckinghaus and
Ghosh, 2009). The family includes five members, namely RelA
(also referred to as p65), c-Rel, RelB, p105/p50 (NF-kB1), and
p100/p52 (NF-kB2). These proteins form homo- and hetero-
dimers, each with a specific set of target genes. NF-kB has
been shown to play an important role in the replication of HIV
and SIV. HIV-1 contains two NF-kB-binding elements in the tran-
scriptional control element of its long terminal repeat region
(LTR) (Nabel and Baltimore, 1987); the LTR of SIVmac features
one such element (Regier and Desrosiers, 1990). While these
NF-kB-binding sites are not absolutely required for viral replica-
tion due to considerable redundancy of cis-acting elements in
this region (Ilyinskii and Desrosiers, 1996; Leonard et al., 1989;
Ross et al., 1991), it has been demonstrated that NF-kB can
drastically enhance LTR-dependent transcription (Nabel and
Baltimore, 1987; Osborn et al., 1989; Perkins et al., 1993), and
that stimulation of infected cells with NF-kB-activating cytokines
can strongly increase replication of HIV-1 (Alcamı´ et al., 1995;
Folks et al., 1989; Griffin et al., 1989).
In this study, we demonstrate that gp41CD has the previously
unrecognized capacity to induce NF-kB activation. This activa-
tion is mediated through the canonical pathway of NF-kB, with
the TGF-b-activated kinase 1 (TAK1) being a critical component
of this signal-transduction event. In fact, we show here that
gp41CD interacts physically with TAK1, and this interaction
requires the same sequences that are required for NF-kB activa-
tion. To establish the physiological relevance of these observa-
tions, we also show that a mutant of HIV-1 deficient in
gp41CD-mediated NF-kB activation exhibits markedly impairedMicrobe 11, 181–193, February 16, 2012 ª2012 Elsevier Inc. 181
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Cytoplasmic Domain of HIV-1 gp41 Activates NF-kBreplication kinetics under conditions of suboptimal cellular stim-
ulation and that its replication can be rescued by external stimu-
lation of the host cell.RESULTS
The Cytoplasmic Domain of gp41 Induces NF-kB
Activation
To isolate gp41CD from the remainder of the envelope protein
(Env), expression cassettes were constructed in which full-
length or truncated derivatives of HIV-1 or SIVmac239 gp41CD
were fused to the external and transmembrane domain of human
CD8a. When cotransfected with an NF-kB-, AP-1-, or NF-AT-
luciferase reporter plasmid in HEK293T cells, the CD8 fusion
constructs allowed us to conveniently and specifically measure
activation of these transcription factors by gp41CD. Use of trun-
cated derivatives of gp41CD (CD8-gp41D) minimized cytotoxic
effects and thereby facilitated unambiguous interpretation of
transcription factor reporter measurements.
The gp41CDs of three different HIV-1 strains truncated at CD
amino acid 71 consistently induced NF-kB activity 35- to 80-fold
depending upon the strain (Figure 1A). One of the HIV-1
gp41CDs that was used was derived from the laboratory strain
NL4-3 (Adachi et al., 1986), while the other two were derived
from clade B primary isolates 92HT593.1 and 92HT596.4 (Gao
et al., 1996). gp41CD of SIVmac239 (Regier and Desrosiers,
1990), truncated at CD amino acid 26 (Env residue 737), consis-
tently inducedNF-kBactivity approximately 20-fold above back-
ground levels (Figure 1B). Neither AP-1- nor NF-AT-dependent
transcription was induced by these constructs (Figures S1A–
S1F). As expected, CD8-gp41 constructs with the full-length
gp41CDs also were able to induce NF-kB, as was an expres-
sion-optimized construct of full-length SIVmac239 Env (Fig-
ure S1G). The lower levels of NF-kB activation observed with
the constructs featuring the complete gp41CD compared to
the truncated versions are likely due at least in part to the cyto-
pathic effects associated with expression of the full cytoplasmic
domain (Chernomordik et al., 1994; Ishikawa et al., 1998; Miller
et al., 1993; Srinivas et al., 1992).
To examine whether gp41CD is also capable of inducing
NF-kB activation in CD4+ T cells, we transfected Jurkat
JPM50.6 cells with CD8-gp41D constructs. This cell line is
a CARD11-deficient Jurkat clone that is stably transfected with
an NF-kB-dependent GFP reporter plasmid (Wang et al.,
2002). Cells transfected with CD8-gp41D derived from HIV-1
NL4-3 (Figure S1H, left panel) or from SIVmac239 (Figure S1H,
right panel) consistently expressed higher levels of GFP thanFigure 1. The Cytoplasmic Domain of gp41 Induces NF-kB Activation
HEK293T cells were transiently cotransfected with NF-kB-dependent luciferas
plasmid. Activity of b-galactosidase in each sample was used as a normalization fa
to transfection with the vector backbone (pcDNA3.1). Values are the average of at
constructs had similar levels of expression, as verified by western blot (data not sh
to a stop codon, numbered according to their position in full-length envelope.
92HT596.4 is shown. Each CD8-gp41D construct was truncated at CD amino acid
a CD8 expression construct without any cytoplasmic domain. In (B), activation of
is the same as (A), but includes the corresponding CD8-gp41D constructs trunca
92HT596.4. (D) shows activation of NF-kB by progressively truncated gp41CD s
sequences used in this study is shown. Sequences critical for NF-kB activation a
Cell Host &control-transfected cells, as measured by flow cytometry. Simi-
larly, JPM50.6 cells transfected with an expression cassette en-
coding full-length Env of HIV-1 NL4-3 exhibited higher levels of
GFP fluorescence than cells transfected with Env truncated
immediately C-terminal to the membrane-spanning domain, at
residue G709 (Figure S1I).The NF-kB-Activating Property of gp41CD Maps to
a Conserved Region within the Cytoplasmic Domain
Progressive C-terminal deletions of 10–12 amino acids were
introduced into CD8-gp41D constructs in order to define
sequences required for the observed activation of NF-kB. Trun-
cation of an additional 12 amino acids from the three already
truncated HIV-1 gp41CDs shown in Figure 1A led to a dramatic
loss of the NF-kB-inducing activity (Figure 1C). These 12 amino
acids are CLFSYHRLRDLL in all three HIV-1 strains (Figure 1E).
Similarly, truncation of SIVmac239 gp41CD sequences by an
additional 13 amino acids also led to the loss of the induced
NF-kB activity (Figure 1D). The sequences in SIVmac239
important for the NF-kB induction by these criteria are
VFSSPPSYFQQTH (Figure 1E).
Having identified these regions as required for NF-kB activa-
tion, we endeavored to identify specific amino acids of impor-
tance for this signaling activity. We therefore mutated several
amino acids alone or in combination based on their biochemical
properties and their potential for being part of a signaling motif
(Figure 2). Tyrosine 766 in the NL4-3 sequence (the Y of YHRL)
was particularly important for NF-kB activation (Figures 2A and
2B). The tyrosine at this position is extremely well conserved
among group M, group N, and group O strains of HIV-1 and
SIVcpz; it is present in 174 of 176 sequences examined (Kuiken
et al., 2009). The critical amino acids tyrosine 766 and leucine
769 are contained within a sequence, YHRL, that conforms to
the consensus motif for clathrin-mediated endocytosis, YXXF
(where X describes any and F describes a hydrophobic amino
acid) (Marks et al., 1997). However, it has been shown that this
particular HIV-1 gp41CD YHRL sequence does not significantly
mediate Env endocytosis (Boge et al., 1998; Rowell et al., 1995).
Moreover, disruption of the established dominant endocytosis
motif of gp41CD, 712YSPL715, did not affect gp41CD-mediated
NF-kB activation (Figure 2A, mutant Y712A). Therefore, the
sequence requirements for gp41CD-induced activation of
NF-kB appear to be unrelated to clathrin-mediated endocytosis.
The motif YXXF also describes a common consensus
sequence for SH2 binding (Machida and Mayer, 2005). SH2
binding requires the tyrosine of the consensus sequence to be
phosphorylated, and mutating this tyrosine to a phenylalaninee, constitutively expressed b-galactosidase, and a CD8-gp41D or a control
ctor. Results are given as fold induction of normalized luciferase activity relative
least three independent experiments. Error bars indicate standard deviation. All
own). Designations on abscissa indicate the respective amino acids converted
In (A), activation of NF-kB by gp41CD of HIV-1 strains NL4-3, 92HT593.1, or
71, i.e., L774 for NL4-3, L793 for 92HT593.1, L774 for 92HT596.4. CD8-stop is
NF-kB by gp41CD of SIVmac239, truncated at Env amino acid I737, is seen. (C)
ted at CD amino acid 59, i.e., C762 for NL4-3, C781 for 92HT593.1, C762 for
equences of SIVmac239. In (E), sequence alignment of the truncated gp41CD
re underlined. See also Figure S1.
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Figure 2. Characterization of Amino Acids Relevant for the Induction of NF-kB Activation by gp41CD
Luciferase assays as described for Figure 1 are shown: (A) effect of point mutations in gp41CD of HIV-1 NL4-3, (B) effect of specific point mutations of Y766 in
gp41CD of HIV-1 NL4-3, and (C) effect of point mutations in gp41CD of SIVmac239.
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Cytoplasmic Domain of HIV-1 gp41 Activates NF-kBtypically abrogates SH2 binding and signaling. However,
mutating tyrosine 766 to a phenylalanine did not decrease
NF-kB activation; in fact, it increased activation slightly (Fig-
ure 2A). These results indicate that conventional SH2 binding is
not involved in the observed phenomenon. Conversely, intro-
ducing a negative charge bymutating tyrosine 766 to a glutamate
or aspartate strongly reduced gp41CD-induced NF-kB activa-
tion, as did a mutation to serine (Figure 2B).
Similarly, mutating the central tyrosine of the sequence crit-
ical for NF-kB activation by SIVmac239 gp41CD, tyrosine 731,
to the negatively charged glutamate reduced the observed
NF-kB activation markedly (Figure 2C). Tyrosine 731 is also
well conserved across SIVmac, HIV-2, SIVmne, SIVsmm, and
SIVstm, being present in 65 out of 68 sequences examined
(Kuiken et al., 2009). As we saw with gp41CD of HIV-1, disrup-
tion of the membrane-proximal endocytosis motif 721YRPV724 of
SIV by mutating tyrosine 721 to alanine (LaBranche et al., 1995)
did not affect gp41CD-induced NF-kB activation (data not
shown).
A High-Throughput siRNA Screen Identifies
Components of the Canonical NF-kB Pathway
Wenext used a prevalidated siRNA collection to characterize the
specific NF-kBpathway utilized by gp41CD. Expression levels of
42 key regulators of NF-kB were individually knocked down in
HEK293T cells, after which NF-kB induction by CD8-gp41D
was quantified in luciferase reporter assays (Figures 3 and S2).
The knockdowns affected NF-kB activation by gp41CD of
HIV-1 NL4-3 (Figure 3A) and SIVmac239 (Figure 3B) in a very
similar pattern, indicating conservation of pathway utilization
despite a lack of significant sequence similarities between the
NF-kB-activating regions of gp41CD of HIV-1 and SIV (Fig-
ure 1E). Most notably, inhibition of expression of the proteins
TGF-b-activated kinase 1 (TAK1), NF-kB essential modulator
(NEMO or IKKg, encoded by gene IKBKG), and of the NF-kB
subunit RelA markedly reduced NF-kB activation. The specificity
and efficiency of the knockdown of these three genes was veri-
fied by western blot (Figure 3C). TAK1 is a serine/threonine
kinase which phosphorylates and thereby activates the inhibitor
of kB kinase (IKK) complex (Wang et al., 2001), while NEMO
forms the regulatory subunit of the IKK complex (Yamaoka
et al., 1998). Both TAK1 and NEMO are indispensable compo-
nents of canonical NF-kB activation, but neither is involved in
the noncanonical pathway. This implies that gp41CD activates
NF-kB via the canonical pathway.
The Cytoplasmic Domain of gp41 Increases the Levels
of Activated Nuclear RelA
As the siRNA screen suggested RelA to be the dominant NF-kB
subunit activated by gp41CD, we tested whether expression of
CD8-gp41D leads to an increase in nuclear RelA capable of
binding to the NF-kB consensus nucleotide sequence. Consis-
tent with the siRNA results, an oligonucleotide pull-down
demonstrated that substantially more RelA in the nuclear fraction
of cells expressing CD8-gp41D binds to the NF-kB-binding
sequence than in the nuclear fraction of cells expressing CD8
without a cytoplasmic domain (CD8-stop) or of untransfected
cells (Figure 4). Importantly, the NF-kB-binding sequence of
the biotinylated probe used in these experiments correspondsCell Host &to the sequence of the second NF-kB-binding site in the HIV-1
LTR (Nabel and Baltimore, 1987). No RelA could be detected
when a 10-fold excess of unlabelled probe was added to the bio-
tinylated NF-kB-binding probe or when the biotinylated NF-kB-
binding probe was mutated to include a single-nucleotide
substitution which disrupts RelA binding.
TAK1 is Crucial for Effective Activation of NF-kB by the
Cytoplasmic Domain of gp41
To further confirm the central role of TAK1 suggested by the
siRNA screens, the effect of the dominant-negative TAK1mutant
K63W (Yamaguchi et al., 1995) on gp41CD-mediated NF-kB
activation was assessed. Indeed, overexpression of TAK1
K63W reduced NF-kB activation by 80% (Figure 5A). Similarly,
the chemical TAK1 inhibitor (5Z)-7-Oxozeaenol (Ninomiya-Tsuji
et al., 2003) was able to markedly diminish the NF-kB activation
induced by expression of CD8-gp41D (Figure 5B). Together,
these results unambiguously corroborate the importance of
TAK1 for gp41CD-mediated NF-kB activation.
The Cytoplasmic Domain of gp41 Interacts Specifically
with TAK1
Next, we sought to identify cellular partners of gp41CD respon-
sible for the initiation of the signal transduction cascade. FLAG-
tagged versions of candidate proteins were coexpressed in
HEK293T cells with gp41CD derived from NL4-3 and truncated
at Env residue 774, fused to mammalian glutathione-S-trans-
ferase (GST-gp41D L774*). No coprecipitation of the proteins
retinoic acid-inducible gene-I (RIG-I), casein kinase 1a1
(CSNK1A1), tumor necrosis factor receptor-associated factor 6
(TRAF6), or tumor necrosis factor receptor type 1-associated
DEATH domain (TRADD) with the gp41CD sequences was
observed. However, TAK1 specifically and efficiently coprecipi-
tated with the HIV-1 gp41CD sequences (Figure 6A). Further
truncation of GST-gp41D by 12 amino acids to Env residue
762 resulted in complete loss of association with TAK1 (Fig-
ure 6B), precisely mirroring the loss of NF-kB activation by
CD8-gp41Dconstructswith the very same truncation (Figure 1C).
Specific coprecipitation of TAK1 was also observed with
GST-gp41 constructs with the full-length gp41CD of NL4-3 (Fig-
ure 6C). TAK1 did not detectably coprecipitate with a GST-
gp41D construct based on SIVmac239 (data not shown), consis-
tent with the low similarity between the NF-kB-activating
gp41CD sequences of HIV-1 and SIV (Figure 1E).
We further studied this interaction of HIV-1 gp41CD with TAK1
by examining their subcellular localization in transiently trans-
fected HeLa cells by confocal microscopy (Figure S3). Consis-
tent with the specific coprecipitation of TAK1 by gp41CD,
CD8-gp41D L774* (HIV-1 NL4-3) colocalized with TAK1,
whereas this colocalization was strongly reduced in cells trans-
fected with the nonsignaling construct CD8-gp41D C762* (Fig-
ure S3A). Furthermore, full-length Env of HIV-1 NL4-3 also colo-
calized with TAK1 (Figure S3B).
NF-kB Activation by HIV-1 gp41CD Plays an Important
Role in Viral Replication under Conditions of Suboptimal
Cellular Activation
An IL-2-dependent, CD4+ human T cell line, WE17/10 (Willard-
Gallo et al., 1990), was used to evaluate the physiologicalMicrobe 11, 181–193, February 16, 2012 ª2012 Elsevier Inc. 185
Figure 3. The Cytoplasmic Domain of gp41 Induces NF-kB through the Canonical Pathway
(A) siRNA screen with CD8-gp41D L774* (gp41CD sequences of isolate HIV-1 NL4-3). Expression of 42 different key regulators in the NF-kB pathway was
knocked down by siRNA in HEK293T cells prior to NF-kB-dependent luciferase assays. Results are presented as percentage of normalized luciferase activity
relative to transfection with nonsense siRNA (NEG). NOR, transfection without RNA. Note that ordinate is cut off at 100% for better interpretability. See Figure S2
for values larger than 100%. Values indicate the average of three independent experiments. Error bars represent standard deviation.
(B) siRNA screen as (A), but with CD8-gp41D I737* (gp41CD sequences of isolate SIVmac239).
(C) Verification of the knockdown specificity for NEMO (encoded by gene IKBKG), TAK1, and RelA, by western blot of the samewhole-cell lysate also used for the
luciferase assays.
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Cytoplasmic Domain of HIV-1 gp41 Activates NF-kBrelevance of the NF-kB-activating function of gp41CD by
measuring the ability of virus to replicate under conditions of
suboptimal cellular stimulation. The parental HIV-1 NL4-3 virus
was compared to the Env mutant Y766S. This mutation signif-
icantly impairs the ability of gp41CD sequences to activate
NF-kB (Figure 2B), but it does not affect the amino acid
sequence encoded by the overlapping reading frame of the
second exon of rev. The Env Y766S mutation did not signifi-
cantly influence the ability of virus to infect LTR_SEAP-
CEMx174 cells (Means et al., 1997) or the TZM-bl reporter
cell line (Derdeyn et al., 2000) (Figures 7A and 7B). Further-
more, wild-type and mutant virus replicated at similar levels186 Cell Host & Microbe 11, 181–193, February 16, 2012 ª2012 Elsein fully activated, human peripheral blood mononuclear cells
(PBMC) isolated from two separate individuals (Figures 7C
and 7D). However, when cultured with a low concentration
of IL-2, the replication of the Env Y766S mutant was severely
impaired in WE17/10 cells, while wild-type virus replicated effi-
ciently (Figure 7E). Importantly, this impairment of the Env
Y766S mutant could be largely overcome by stimulating the
cells with phytohemagglutinin (PHA) (Figure 7F), a plant lectin
capable of activating lymphocytes. This result implies an
important role for gp41CD-mediated NF-kB activation in over-
coming the restrictions posed to viral replication by a subopti-
mally activated cell.vier Inc.
Figure 4. The Cytoplasmic Domain of HIV-1
gp41 Induces an Increase in Activated
Nuclear RelA
Oligonucleotide pull-down was performed as
described previously (de Jong et al., 2010).
HEK293T cells were transfected with CD8-gp41D
L774* (HIV-1 NL4-3) or CD8-stop. Nuclear
extracts were normalized for protein concentra-
tion and incubated with double-stranded, bio-
tinylated oligonucleotides encoding the NF-kB
consensus binding sequence (BT-NF-kB wild-
type); with BT-NF-kB wild-type and a 10-fold
excess of unbiotinylated NF-kB consensus
binding sequence as competition control (10x
NF-kB wild-type); or with biotinylated NF-kB
consensus sequence with a single-nucleotide
substitution which abrogates NF-kB binding as
specificity control (BT-NF-kB mutant). Bio-
tinylated oligonucleotides were precipitated with
streptavidin (SA)-linked sepharose beads and levels of bound RelA assessed by western blot. Data are representative of four independent experiments with
identical results. WCL, whole-cell lysate; Prec, precipitation; WB, western blot; UT, untransfected.
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It has long been established that HIV-1 replicates optimally in
T cells that are fully activated (McDougal et al., 1985; Stevenson
et al., 1990; Zagury et al., 1986). The data presented here estab-
lish a role for gp41CD of both HIV-1 and SIVmac in inducing
NF-kB activation, a hallmark of lymphocyte activation. For
HIV-1, this induction is mediated by an interaction with TAK1,
and the NF-kB-activating capacity is evidently important for
the virus’s ability to replicate in cells under conditions of limited
cellular activation.
TAK1 is a highly conserved key regulator of NF-kB activation.
Several branches of the canonical NF-kB pathway converge on
TAK1, including signal transduction cascades induced by tumor
necrosis factor a (TNFa), interleukin-1b (IL-1b), lipopolysaccha-
ride, viral RNA, cellular DNA damage, as well as complexes of
antigen and major histocompatibility complex. According to theCell Host &current model of canonical NF-kB activation, NF-kB dimers are
retained in the cytoplasm by a family of inhibitor of kB (IkB)
proteinsduring the inactive state. Anexternal stimulus can induce
a signal transduction cascade culminating in the recruitment of
TAK1 and NEMO, the regulatory subunit of the IKK complex,
into closeproximity of eachother throughascaffoldofK63-linked
polyubiquitin chains. This allows TAK1 to phosphorylate IKKb
and thereby activate the IKK complex, which then phosphory-
lates IkB proteins, leading to proteasomal degradation of IkB
and nuclear translocation of NF-kB to activate transcription of
its target genes (Adhikari et al., 2007; Liu and Chen, 2011; Wertz
andDixit, 2010). gp41CDofHIV-1might intersect this pathwayby
acting asamolecular bridgebetweenTAK1and the IKKcomplex;
alternatively, gp41CD might nucleate a larger signaling complex
including an E3 ubiquitin ligase capable of providing K63-linked
polyubiquitination. The observation that neither TRAF6 nor
TRADD, both NF-kB pathway components situated ‘‘upstream’’Figure 5. Specific Inhibition of TAK1Reduces Acti-
vation of NF-kB by gp41CD of HIV-1
(A) HEK293T cells were cotransfected with NF-kB-
dependent luciferase, constitutively expressed b-galac-
tosidase, CD8-gp41D L774* (HIV-1 NL4-3), and either
vector backbone (pcDNA3.1) or FLAG-tagged TAK1
K63W. Activity of b-galactosidase in each sample was
used as normalization factor. Results are given as
percentage of normalized luciferase activity relative to
transfection with pcDNA3.1.
(B) HEK293T cells were cotransfected with NF-kB-
dependent luciferase, constitutively expressed b-galac-
tosidase, and CD8-gp41D L774* (HIV-1 NL4-3). Fourteen
hours after transfection, cells were treated with the
chemical TAK1 inhibitor (5Z)-7-Oxozeaenol at a final
concentration of 300 nM or an equivalent volume of
dimethyl sulfoxide (DMSO). Activity of b-galactosidase in
each sample was used as normalization factor. Results
are given as percentage of normalized luciferase activity
relative to treatment with DMSO. Values are the average of
three independent experiments. Error bars indicate stan-
dard deviation. Expression levels of CD8-gp41D were not
affected by coexpression with TAK1 K63W or the pres-
ence of (5Z)-7-Oxozeaenol, as verified by western blot.
Microbe 11, 181–193, February 16, 2012 ª2012 Elsevier Inc. 187
Figure 6. The Cytoplasmic Domain of HIV-1 gp41 Specifically Interacts with TAK1
HEK293T cells were cotransfected with the indicated constructs. After 37 hr, GST fusion proteins were precipitated with glutathione beads, followed by
immunoblotting. In (A), coprecipitation of FLAG-tagged RIG-I, CSNK1A1, TRAF6, TRADD, or TAK1 with GST-gp41D L774* (HIV-1 NL4-3) is seen. (B) shows
coprecipitation of FLAG-tagged TAK1 with GST-gp41D L774*, GST-gp41D C762* (both HIV-1 NL4-3), or GST. In (C), coprecipitation of FLAG-tagged TAK1 with
full-length gp41CD (HIV-1 NL4-3) fused to GST, or with GST alone, is shown. Prec, precipitation; WB, western blot; GSH, glutathione; GST, glutathione-
S-transferase; WCL, whole-cell lysate. Results are representative of at least three independent experiments. See also Figure S3.
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Cytoplasmic Domain of HIV-1 gp41 Activates NF-kBof TAK1 in the IL-1b- and TNFa-induced signaling cascades
respectively, detectably coprecipitated with gp41CD lends
credence to the notion that HIV-1 gp41CD circumvents the initial
steps of canonical NF-kB activation and directly intersects this
pathway at the level of TAK1.
Interestingly, recent reports indicate that at least two other
viruses may also have evolved means of co-opting TAK1 for
the purpose of NF-kB activation (Bottero et al., 2011; Wu and
Sun, 2007). Although the exact regions of TAK1 interaction for
these two instances have not been mapped, it is noteworthy
that a remarkable sequence similarity exists between the region
of HIV-1 gp41CD reported here to be crucial for NF-kB activation
(762CLFSYHRLRDLL773) and a region of HHV-8 protein vGPCR,188 Cell Host & Microbe 11, 181–193, February 16, 2012 ª2012 Elsealso reported to activate NF-kB via an interaction with TAK1
(264CFPYHVLNLL273) (Bottero et al., 2011). In addition, two
groups have recently shown that the cellular restriction factor
TRIM5, which efficiently restricts retroviral replication in
a capsid-dependent manner (Stremlau et al., 2004), also inter-
acts functionally with TAK1 and induces NF-kB activation (Pertel
et al., 2011; Tareen and Emerman, 2011). Further studies will be
needed to determine if there is a functional connection between
the observation of TAK1 as a target of TRIM5 activity and the
interaction between gp41CD and TAK1 to induce NF-kB activa-
tion which we report here. For example, gp41CD could conceiv-
ably subvert TRIM5 function by recruiting and sequestering
TAK1 away from TRIM5.vier Inc.
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Figure 7. The Ability of gp41CD to Induce NF-kB Activation Is Critical for Viral Replication in Suboptimally Activated Cells, but Not in Fully
Activated Cells
(A–F) For all panels: , HIV-1 NL4-3;, HIV-1 NL4-3 Env Y766S. (A) and (B) show infectivities of HIV-1 NL4-3 wild-type and the Env Y766S mutant. Cells were
infected with virus doses containing the indicated amount of p24. (A) Infectivities in LTR_SEAP-CEMx174 cells. Activity of SEAP in the supernatant wasmeasured
3 days after infection. (B) Infectivities in TZM-bl cells. Activity of luciferase was determined 3 days after infection. (C)–(F) show replication of HIV-1 NL4-3 wild-type
and the Env Y766S mutant in human PBMC and WE17/10 cells. Cells were infected with HIV-1 doses containing 10 ng p24. Concentration of p24 in the
supernatant was determined every 3–4 days. (C) and (D) Replication in fully activated human PBMC isolated from two different individuals. (E) and (F) Replication
inWE17/10 cells. (E) Infection of cells cultured under conditions of suboptimal stimulationwithout phytohemagglutinin. (F) Infection of cells stimulated by culturing
with 2 mg/ml phytohemagglutinin. SEAP, secreted alkaline phosphatase; RLU, relative light units.
Cell Host & Microbe
Cytoplasmic Domain of HIV-1 gp41 Activates NF-kBWhile NF-kB activation by gp41CD is evolutionarily conserved
between HIV-1 and SIVmac, NF-kB activation by SIVmac
gp41CD is apparently not mediated by binding to TAK1, and
the sequences used by SIVmac gp41CD are quite different
from those used by HIV-1 gp41CD. Nonetheless, the siRNA
screen reported here indicates an important role for TAK1 in
SIVmac gp41CD-induced NF-kB activation. It therefore seems
likely that gp41CD of SIVmac manipulates the NF-kB pathway
at the level of a regulatory enzyme located ‘‘upstream’’ of
TAK1. The exact mechanisms by which SIVmac gp41CD
induces NF-kB will require further investigation.Cell Host &An incoming virus brings only about 7–16 envelope trimers to
a cell following fusion of the virion with the plasma cell membrane
(Chertova et al., 2002; Yuste et al., 2004; Zhu et al., 2003). While
this may be sufficient, it seems like a small number to induce
significant levels of NF-kB activation. It is also possible that
low levels of Env expression inside a resting or minimally acti-
vated T cell may induce a small degree of activation, thus aug-
menting the levels of viral gene expression, resulting in a positive
feedback loop of steadily increasing cellular activation and viral
gene expression. One of the functions of the virally encoded
early gene product Nef is to increase the state of cellularMicrobe 11, 181–193, February 16, 2012 ª2012 Elsevier Inc. 189
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Cytoplasmic Domain of HIV-1 gp41 Activates NF-kBactivation (Alexander et al., 1997; Fenard et al., 2005; Simmons
et al., 2001). Sequential expression of Nef and Env, a late gene
product, may contribute to such a feedback loop of increasing
NF-kB activation. It is also possible that Env may serve to
complement or modify the lymphocyte activation induced by
Nef at a later point in the virus’s life cycle, possibly by activating
a different combination of NF-kB homo- or heterodimers and
thereby a different subset of target genes. This notion is consis-
tent with the observation that Nef induces a transcriptional
profile in T cells which is remarkably similar to the pattern
induced by a single activating stimulus (Simmons et al., 2001),
whereas T cells typically require two independent stimuli for
full activation (Janeway and Bottomly, 1994; Linsley and Ledbet-
ter, 1993). Such a feedback mechanism might contribute
significantly to the residual replication of HIV-1 observed in unsti-
mulated lymphocytes (McDougal et al., 1985) and play an impor-
tant role for viral replication in vivo, where the virus is likely to
continuously encounter non- or suboptimally activated
lymphocytes.
EXPERIMENTAL PROCEDURES
Cell Lines
HEK293T/17 cells (ATCC, Manassas, VA), TZM-bl cells (Derdeyn et al., 2000)
(NIH AIDS Research and Reference Reagent Program [NIH ARRRP]), and
LTR_SEAP-CEMx174 cells (Means et al., 1997) were maintained using stan-
dard tissue-culture techniques and conditions. WE17/10 cells (Willard-Gallo
et al., 1990) (NIH ARRRP) were maintained in RPMI 1640 medium supple-
mented with 20% Fetal Bovine Serum (FBS) (Invitrogen, Carlsbad, CA) and
50 U/ml interleukin-2 (IL-2) (Lahm and Stein, 1985) (NIH ARRRP). Note that
50 U/ml IL-2 is only half the concentration recommended for this cell line.
This low concentration was chosen to maintain a state of suboptimal cellular
activation, unless stimulated by the addition of PHA.
Plasmids, Cloning, and Site-Directed Mutagenesis
CD8-gp41 constructs were created in vector pcDNA3.1(+) (Invitrogen) by
fusing the extracellular and transmembrane domain of human CD8a to the
cytoplasmic-domain sequences of gp41 of SIVmac239 (Regier and Desros-
iers, 1990), HIV-1 NL4-3 (Adachi et al., 1986), HIV-1 92HT593.1, or HIV-1
92HT596.4 (Gao et al., 1996) (all from NIH ARRRP). Truncations and point
mutations of CD8-gp41 constructs were introduced by site-directedmutagen-
esis, using the QuikChange II kit (Agilent Technologies, Santa Clara, CA). An
HA tag flanked by glycine linkers was inserted immediately C-terminally to
the signal peptide of CD8a in CD8-g41D constructs. GST-gp41 constructs
were created analogously, by cloning the respective gp41CD sequences
into vector pEBG, which was a kind gift from Michaela Gack (Harvard Medical
School). The cDNA sequences of CSNK1A1, TRAF6, TRADD, and TAK1 were
obtained from Open Biosystems (Thermo Fisher Scientific, Huntsville, AL),
cloned into pcDNA3.1(+), and furnished with an N-terminal FLAG tag. The
pFLAG-TAK1 K63W mutant was created by site-directed mutagenesis.
Sequence fidelity of every plasmid was verified by DNA sequencing (Retrogen,
San Diego, CA). Expression plasmid pEF-IRES-RIG-I-FLAG was also kindly
provided to us by Michaela Gack (Gack et al., 2007). The following plasmids
were generously provided to us by Jae Jung (University of Southern California):
pEF-IRES-STP-A, the NF-kB-luciferase, AP-1-luciferase, and NF-AT-lucif-
erase reporter plasmids, as well as the b-galactosidase, Fyn, Lck, and Src
expression plasmids (Garcia et al., 2007). The RNA-optimized SIVmac239
envelope expression vector pEEO239 was a kind gift from George Pavlakis
(NCI Frederick) (Rosati et al., 2005). The F725* truncation was introduced
into pEEO239 by site-directed mutagenesis.
Luciferase Reporter Assays
For luciferase reporter assays, HEK293T cells were transfected with the indi-
cated plasmids using FuGENE 6 (Roche, Indianapolis, IN). Thirty-seven hours
after transfection, cells were harvested and lysed, and activity of luciferase190 Cell Host & Microbe 11, 181–193, February 16, 2012 ª2012 Else(Luciferase Assay System, Promega, Madison, WI) and b-galactosidase (Gal-
acto-Light Plus Assay System, Applied Biosystems, Carlsbad, CA) were quan-
tified. Each luciferase reporter experiment was performed with triplicate
samples. Additionally, results given are the average of at least three indepen-
dent experiments.
siRNA Screens
siRNA screens were performed using SureSilencing siRNA Arrays for
Human NFkB Signaling (SABiosciences, Frederick, MD). HEK293T cells
were transfected with the respective precoated siRNA pairs (‘‘reverse
transfection’’) using SureFECT transfection reagent (SABiosciences). After
24 hr, cells were cotransfected with CD8-gp41D, luciferase reporter
plasmid, and b-galactosidase using FuGENE 6. Thirty-seven hours after
the second transfection, luciferase and b-galactosidase activity were quan-
tified. Results are given as the percentage of normalized luciferase activity
relative to transfection with nonsense siRNA. Values are the average of at
least three independent experiments. For NEMO knockdowns, cells were
transfected with IKBKG-specific Silencer siRNA 139260 (Applied Bio-
systems) using Dharmafect I (Thermo Fisher Scientific) and then treated
analogously.
Oligonucleotide Pull-Down Experiments
Oligonucleotide pull-down experiments were performed essentially as
described previously (de Jong et al., 2010). In brief, HEK293T cells were trans-
fected with CD8-gp41D L774* (HIV-1 NL4-3) or CD8-stop, using FuGENE 6.
After 48 hr, cells were harvested and the nuclear fraction isolated with the
BioVision Nuclear/Cytosol Fractionation Kit (BioVision, Mountain View, CA),
according to the manufacturer’s instructions. Nuclear extracts were normal-
ized for protein concentration and incubated on ice with 50 pmol double-
stranded, 50-biotinylated oligonucleotide probe (Sigma-Aldrich, St. Louis,
MO) in Band Shift Buffer (0.5% NP-40 [Thermo Scientific, Rockford, IL];
50 mM KCL; 50 mM Tris, pH 7.5) supplemented with 50 mg/ml poly(dI:dC)
(Sigma-Aldrich) and 1 mM DTT (BioVision). In specificity controls, 50 pmol
50-biotinylated oligonucleotide probe was supplemented with 500 pmol
unbiotinylated oligonucleotide probe of the same sequence. Specificity of
binding was further verified in a separate set of controls by using 50 pmol of
50-biotinylated oligonucleotide probe with a single-nucleotide substitution
which abrogates NF-kB binding. After incubation with nuclear extract, bio-
tinylated probes were precipitated with streptavidin-coated sepharose beads
(GE Healthcare, Piscataway, NJ). Relative amount of RelA protein bound to
oligonucleotide probes and precipitated with them was assessed by western
blot.
Glutathione Precipitation Experiments
For precipitation experiments, HEK293T cells were transfected with the indi-
cated constructs, using FuGENE 6. Thirty-seven hours later, cells were
harvested and lysed with NP-40 lysis buffer (1% NP-40, 50 mM HEPES [Invi-
trogen], 150 mM NaCl) supplemented with Complete protease inhibitor cock-
tail (Roche). Cellular debris was pelleted by centrifugation for 25min at 4Cand
1.6$104 rcf. An aliquot of supernatant was stored as a whole-cell lysate
sample.
For glutathione precipitation, the remaining cell lysate was incubated with
Glutathione Sepharose 4B beads (GE Healthcare) for 4–6 hr at 4C. Beads
were then washed 5 times with 1 ml NP-40 lysis buffer (supplemented with
Complete protease inhibitor cocktail). Finally, bound protein was eluted by re-
suspending the beads in Laemmli Buffer (Sigma-Aldrich) and used for western
blotting.
Antibodies
The following primary antibodies were used in this study: mouse anti-GST,
mouse anti-FLAG, rabbit anti-FLAG (all Sigma-Aldrich), mouse anti-HA,mouse
anti-NEMO, rabbit anti-b-Tubulin, rabbit anti-TAK1, rabbit anti-RelA (all Cell
Signaling Technology, Danvers, MA), mouse anti-b-Actin (Abcam, Cambridge,
MA), mouse anti-SP1 (Santa Cruz Biotechnology, Santa Cruz, CA). As
secondary antibodies, goat anti-mouse IgG-HRP and goat anti-rabbit IgG-
HRP (both Santa Cruz Biotechnology) were used. Western blots were per-
formed using standard techniques.vier Inc.
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The Env Y766S mutation (nucleotide A8517C) was introduced into the proviral
genome of HIV-1 NL4-3 (NIH ARRRP, GenBank ID AF324493.2) (Adachi et al.,
1986) by site-directed mutagenesis and verified by DNA sequencing. Virus
stocks were generated as previously described (Bixby et al., 2010). Concen-
tration of virus in the supernatant was determined by a p24 antigen-capture
assay (Advanced BioScience Laboratories, Kensington, MD).Infectivity Assay
Viral infectivity was determined by infection of the reporter cell lines
LTR_SEAP-CEMx174 (Means et al., 1997) and TZM-bl (Derdeyn et al.,
2000), essentially as described previously (Bixby et al., 2010). Cells were in-
fected with virus at a series of 2-fold dilutions. On day 3 after infection, activity
of SEAP in the supernatant (Phospha-Light kit, Applied Biosystems) or lucif-
erase (Luciferase Assay System, Promega) was quantified.Assay of Virus Replication
Human PBMC of healthy volunteers were isolated as described previously
(Bixby et al., 2010) and infected with 10 ng p24 equivalent of either HIV-1
NL4-3 or HIV-1 NL4-3 Env Y766S. Supernatant concentrations of p24 were
measured by p24 antigen-capture assay every 3–4 days.
WE17/10 cells were resuspended in fresh medium on the day of infection,
either with or without 2 mg/ml PHA. Both sets of cells were then infected
with 10 ng p24 equivalent of either HIV-1 NL4-3 or HIV-1 NL4-3 Env Y766S.
Supernatant concentrations of p24 were measured by p24 antigen-capture
assay every 3–4 days.
For more details, see Supplemental Experimental Procedures in the Supple-
mental Information.SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/j.
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